| [1] |
chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al..
Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with
[J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
|
| [2] |
Shi Yingying, Wang Yuanxi..
Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
|
| [3] |
Min Feng, Huang Wenqi, Wu Weibing, et al..
Implications of serum adipocytokine levels in patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
|
| [4] |
patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al..
Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in
[J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
|
| [5] |
chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin..
Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in
[J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
|
| [6] |
Ma Liying, Shen Lijuan..
Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads
[J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
|
| [7] |
Li Chuanjie, Xu Jing, Wang Liangliang, et al..
Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment
[J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
|
| [8] |
Du Keye, Yang Dongliang, Liu Jia.
Regulatory T cells in hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
|
| [9] |
Liao Guichan, Peng Jie, Zhang Xiaoyong.
Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection
[J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
|
| [10] |
Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al.
Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
|
| [11] |
Tu Jiexia, Wang An’na, Liao Ruoxi.
Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
|
| [12] |
Gao Wei, Hou Yong.
Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
|
| [13] |
Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al.
Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure
[J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
|
| [14] |
Zhang Mei, Shi Xiuying, Li Linjuan, et al.
Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus
[J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
|
| [15] |
Bai Yichun, Deng Jihong, Mei Xiaoping.
Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.
|
